Cervical cancer.
The stage estimated by clinical FIGO staging is the main determinant in guiding the treatment decisions. However, clinical FIGO staging does have inherent inaccuracies, because it does not include significant prognostic factors. Presently, MRI is not officially incorporated in the staging workup system; however, it is widely accepted as the most reliable imaging modality in evaluating cervical cancer and in treatment planning. MRI offers direct tumor visualization, accurate assessment of the depth of stromal invasion and tumor volume, lymph node evaluation, and reliable staging accuracy. Published reports show the superiority of MRI over clinical staging, and several recent works on dynamic MRI suggest further improvement of MRI in evaluating cervical cancer.
Togashi
K
K
Department of Radiology and Nuclear Medicine, Kyoto University, Sakyo, Japan.
Morikawa
K
K
Kataoka
M L
ML
Konishi
J
J
D003287:Contrast Media; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008279:Magnetic Resonance Imaging / Q000379:methods; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D009367:Neoplasm Staging / Q000379:methods; D002583:Uterine Cervical Neoplasms / Q000473:pathology*
D003287:Contrast Media